Selegiline in the treatment of Parkinson's disease: its impact on orthostatic hypotension

Author： Bhattacharya K.F. Nouri S. Olanow C.W. Yahr M.D. Kaufmann H.

Publisher： Elsevier

ISSN： 1353-8020

Source： Parkinsonism and Related Disorders, Vol.9, Iss.4, 2003-03, pp. : 221-224

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Orthostatic hypotension in Parkinson's disease

By Perez-Lloret Santiago Rey María Verónica Pavy-Le Traon Anne Rascol Olivier

Neurodegenerative Disease Management, Vol. 3, Iss. 4, 2013-08 ,pp. : 363-377

Future Medicine

Access to resources Recommend Favorite

Characteristics of orthostatic hypotension in Parkinson's disease

By Oka Hisayoshi Yoshioka Masayuki Onouchi Kenji Morita Masayo Mochio Soichiro Suzuki Masahiko Hirai Toshiaki Ito Yasuhiko Inoue Kiyoharu

Brain, Vol. 130, Iss. 9, 2007-09 ,pp. : 2425-2432

Oxford University Press

Access to resources Recommend Favorite

Orthostatic hypotension and attention in Parkinson’s disease with and without dementia

By Peralta C. Stampfer-Kountchev M. Karner E. Köllensperger M. Geser F. Wolf E. Seppi K. Benke T. Poewe W. Wenning G. K.

Journal of Neural Transmission, Vol. 114, Iss. 5, 2007-05 ,pp. : 585-588

Springer Publishing Company

Access to resources Recommend Favorite

L-DOPS and the treatment of neurogenic orthostatic hypotension

By Vichayanrat Ekawat Low David A Asahina Masato Owens Andrew P Iodice Valeria Galizia Gianluigi Mathias Christopher J

Future Neurology, Vol. 8, Iss. 4, 2013-07 ,pp. : 381-397

Future Medicine

Access to resources Recommend Favorite

Alienation and Authenticity in Parkinson's Disease and Its Treatment

By Mosley Philip E. Hall Wayne Forlini Cynthia Carter Adrian

AJOB Neuroscience, Vol. 5, Iss. 4, 2014-10 ,pp. : 54-56

Taylor & Francis Ltd

Access to resources Recommend Favorite